Urologist David Miller, M.D., M.P.H., is Professor and Chief of the Dow Division of Health Services Research, in the Department of Urology at the University of Michigan.
After graduating from Washington University School of Medicine he completed his general surgery internship and urology residency training at the University of Michigan Health System. He also completed a fellowship in urological oncology at the David Geffen School of Medicine at UCLA.
Dr. Miller serves as Director of the Michigan Urological Surgery Improvement Collaborative (MUSIC). Funded by Blue Cross Blue Shield of Michigan (BCBSM), MUSIC is a consortium of more than 40 urology practices aiming to improve the quality and cost-efficiency of prostate cancer care in the state of Michigan. Until June 2016, Dr. Miller also served as Director of the Michigan Value Collaborative, a BCBSM-funded consortium that aims to help Michigan hospitals achieve their best possible patient outcomes at the lowest reasonable cost.”
Dr. Miller’s clinical practice focuses on the diagnosis and management of patients with prostate and kidney cancer. He also has a broad background in health services research and quality improvement.
Philosophy of Care
“My goal is to help patients understand their diagnosis and to partner with them in personalized treatment decisions that reflect their goals and priorities,” said Dr. Miller. “Once a decision is made, we move forward together with vigor and optimism.”
In his free time, Dr. Miller enjoys cheering on the University of Michigan Wolverines and spending time with his family.
Special Interests and Procedures
Dr. Miller’s clinical interests include prostate cancer, kidney cancer, urologic oncology and robotic surgery.
“I have a broad background in health services research, including substantial experience using claims data and formal training in the advanced statistical methods used in observational data analyses,” said Dr. Miller. “With funding from the Agency for Healthcare Research and Quality and the National Cancer Institute, my longitudinal research agenda focuses on comparative effectiveness research, physician-led collaborative quality improvement, and on understanding the relationship between physician organizations, integrated delivery systems, and the quality and cost of specialty care.”